Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
11 October 2024

Globally recognised healthcare supply chain expert joins Supervisory Board

With over 15 years of experience advising governments and global organisations on improving supply chains for medicines and healthcare products, Prashant Yadav brings a wealth of expertise in advancing healthcare access worldwide as he joins the Access to Medicine Foundation’s Supervisory Board.

Prashant Yadav has been actively engaged with the Foundation for several years, serving as a member of the Expert Review Committee for the Access to Medicine Index in 2024, 2022 and 2018. In addition, he was a member of the 2022 Expert Review Committee for the Generic & Biosimilar Medicines Programme. His extensive experience with the Foundation demonstrates his deep understanding of its mission and his commitment to advancing health equity on a global scale.

“Joining the Access to Medicine Foundation's Supervisory Board is an honour, especially because I’ve seen firsthand how the Access to Medicines Index triggers real, measurable change in the industry,” Prashant said. “I’m excited to contribute more directly to these efforts, bringing my expertise in healthcare supply chains and pharma industry access strategy to help the Foundation guide pharmaceutical companies in improving access to essential medicines for underserved communities." 

Currently an Affiliate Professor of Technology and Operations at INSEAD, Prashant’s expertise in healthcare supply chains is widely recognised. His work has been featured in prominent print and broadcast media including The Economist, The Financial Times, Nature and the BBC, and his research has earned best paper awards from organisations including the Production and Operations Management Society, INFORMS, and other leading scientific bodies. Prashant has provided expert testimony on medicine supply chains to the US Congress and other legislative bodies worldwide and serves on the advisory boards of various global organisations and social enterprises. 

In his previous roles, Prashant has served as Strategy Leader for Supply Chain at the Bill & Melinda Gates Foundation; Professor of Supply Chain Management at the MIT-Zaragoza International Logistics Program; Research Affiliate at the MIT Center for Transportation and Logistics; Vice President of Healthcare at the William Davidson Institute, and Faculty at the Ross School of Business at the University of Michigan. 

I’m delighted to have Prashant join our Supervisory Board. His extensive knowledge of the healthcare sector and proven solutions for enhancing access in countries with critical needs will play a crucial role in guiding our strategy and mission for positive change.

Jayasree K. Iyer

CEO, Access to Medicine Foundation

News

Read about the latest news at the Foundation
News

Foundation's new report reveals what pharma companies can do to ensure their products reach underserved populations

10 September 2024
News

More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

23 May 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved